tiprankstipranks
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market
NRSN
Neurosense Therapeutics Ltd.
RESEARCH TOOLSreports

Neurosense Therapeutics Ltd. (NRSN) Financial Statements

201 Followers

Neurosense Therapeutics Ltd. Financial Overview

Neurosense Therapeutics Ltd.'s market cap is currently $22.63M. The company's EPS TTM is $-0.235; its P/E ratio is -1.76; Neurosense Therapeutics Ltd. is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -89.00K$ -3.00K
Operating Income$ -11.09M$ -9.90M$ -12.05M$ -13.55M$ -5.59M
EBITDA$ -11.07M$ -9.88M$ -9.64M$ -12.23M$ -2.88M
Net Income$ -11.13M$ -10.21M$ -10.11M$ -12.34M$ -4.04M
Balance Sheet
Cash & Short-Term Investments$ 166.00K$ 3.38M$ 2.64M$ 7.09M$ 11.06M
Total Assets$ 1.03M$ 4.58M$ 3.18M$ 7.71M$ 11.43M
Total Debt$ 170.00K$ 73.00K$ 142.00K$ 211.00K$ 1.83M
Net Debt$ 4.00K$ -3.31M$ -2.50M$ -3.33M$ -9.23M
Total Liabilities$ 2.59M$ 1.99M$ 4.94M$ 2.09M$ 2.42M
Stockholders' Equity$ -1.56M$ 2.58M$ -1.87M$ 5.62M$ 9.01M
Cash Flow
Free Cash Flow$ -7.68M$ -10.14M$ -8.38M$ -7.66M$ -1.56M
Operating Cash Flow$ -7.67M$ -10.13M$ -8.35M$ -7.59M$ -1.54M
Investing Cash Flow$ -8.00K$ 1.00K$ 3.47M$ -3.54M$ -17.00K
Financing Cash Flow$ 4.43M$ 10.91M$ 3.98M$ 3.69M$ 11.90M
Currency in USD

Neurosense Therapeutics Ltd. Earnings and Revenue History

Income Statement >

Neurosense Therapeutics Ltd. Debt to Assets

Balance Sheet >

Neurosense Therapeutics Ltd. Cash Flow

Cash Flow >

Neurosense Therapeutics Ltd. Forecast EPS vs Actual EPS

Earnings >